Amgen Inc.

NASDAQ: AMGN · Real-Time Price · USD
295.12
4.83 (1.66%)
At close: Aug 15, 2025, 12:38 PM

Amgen Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
4.09B 6.72B 6.55B 5.89B
Depreciation & Amortization
5.59B 4.07B 3.42B 3.4B
Stock-Based Compensation
530M 431M 401M 341M
Other Working Capital
-920M -573M 601M -531M
Other Non-Cash Items
141M -991M 1.28B 1.28B
Deferred Income Tax
-1.23B -1.27B -1.2B -453M
Change in Working Capital
2.37B -484M -733M -1.19B
Operating Cash Flow
11.49B 8.47B 9.72B 9.26B
Capital Expenditures
-1.1B -1.11B -936M -880M
Cash Acquisitions
n/a -26.99B -3.73B -2.69B
Purchase of Investments
n/a -1M -2.59B -8.9B
Sales Maturities Of Investments
n/a 1.67B 1.22B 13.23B
Other Investing Acitivies
50M 225M -12M -35M
Investing Cash Flow
-1.05B -26.2B -6.04B 733M
Debt Repayment
-4.26B 25.68B 6.62B 795M
Common Stock Repurchased
-200M n/a -6.36B -4.97B
Dividend Paid
-4.83B -4.56B -4.2B -4.01B
Other Financial Acitivies
-124M -72M -103M -78M
Financial Cash Flow
-9.41B 21.05B -4.04B -8.27B
Net Cash Flow
1.03B 3.31B -360M 1.72B
Free Cash Flow
10.39B 7.36B 8.79B 8.38B